Nutra Pharma Corp (NPHC) stock

NPHCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 1/30

$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $806.69KP/E –Yield –

Nutra Pharma r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2012 it was $3.05K, down 96.6% from the year before.

Period	Period end	Value	Change
FY2012	Dec 31, 2012	$3.05K	-96.6%
FY2011	Dec 31, 2011	$90.87K	-52.6%
FY2010	Dec 31, 2010	$191.79K	–

Parsed from the XBRL in Nutra Pharma's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-40 reverse split on May 18, 2015
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing